Candriam S.C.A. Acquires Shares of 3,852 DaVita Inc. (NYSE:DVA)

Candriam S.C.A. acquired a new stake in shares of DaVita Inc. (NYSE:DVA) in the fourth quarter, Holdings Channel reports. The fund acquired 3,852 shares of the company’s stock, valued at approximately $576,000.

Other hedge funds also recently bought and sold shares of the company. Franklin Resources Inc. lifted its position in shares of DaVita by 134.6% in the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares in the last quarter. FMR LLC lifted its position in shares of DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after purchasing an additional 154,061 shares in the last quarter. Atom Investors LP purchased a new stake in shares of DaVita in the third quarter worth approximately $4,094,000. Assenagon Asset Management S.A. lifted its position in shares of DaVita by 201.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after purchasing an additional 49,885 shares in the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in shares of DaVita in the third quarter worth approximately $726,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Trading Up 3.2 %

Shares of DVA stock opened at $151.72 on Tuesday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The business’s 50 day moving average is $159.47 and its two-hundred day moving average is $157.95. The company has a market cap of $12.14 billion, a PE ratio of 14.13, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.